1. Academic Validation
  2. The dsRNA binding site of human Toll-like receptor 3

The dsRNA binding site of human Toll-like receptor 3

  • Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8792-7. doi: 10.1073/pnas.0603245103.
Jessica K Bell 1 Janine Askins Pamela R Hall David R Davies David M Segal
Affiliations

Affiliation

  • 1 Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, and Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract

Pathogen recognition by Toll-like receptors (TLRs) initiates innate immune responses that are essential for inhibiting pathogen dissemination and for the development of acquired immunity. The TLRs recognize pathogens with their N-terminal ectodomains (ECD), but the molecular basis for this recognition is not known. Recently we reported the x-ray structure for unliganded TLR3-ECD; however, it has proven difficult to obtain a crystal structure of TLR3 with its ligand, dsRNA. We have now located the TLR3 ligand binding site by mutational analysis. More than 50 single-residue mutations have been generated throughout the TLR3-ECD, but only two, H539E and N541A, resulted in the loss of TLR3 activation and ligand binding functions. These mutations locate the dsRNA binding site on the glycan-free, lateral surface of TLR3 toward the C terminus and suggest a model for dsRNA binding and TLR3 activation.

Figures